These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 16365852)
21. Treatment of recurrent or metastatic renal cell carcinoma. Shah RN; Ahmad T; Eisen TG Expert Rev Anticancer Ther; 2004 Dec; 4(6):1069-80. PubMed ID: 15606334 [TBL] [Abstract][Full Text] [Related]
22. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810 [TBL] [Abstract][Full Text] [Related]
23. [Clinical study on the effects of chemotherapy as treatment of renal cell carcinoma]. Onishi T; Iizuka N; Suzuki M; Mori Y; Kondo I; Nakada J; Masuda F; Machida T Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):43-9. PubMed ID: 3379331 [No Abstract] [Full Text] [Related]
24. Immunochemotherapy of metastatic renal cell carcinoma: report of 28 cases. Wang HJ; Chen HX; Li HZ Chin Med J (Engl); 2005 Jan; 118(2):172-3. PubMed ID: 15667805 [No Abstract] [Full Text] [Related]
26. Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma. Chapman AE; Goldstein LJ Semin Oncol; 1995 Feb; 22(1):17-28. PubMed ID: 7855615 [No Abstract] [Full Text] [Related]
27. Genitourinary malignancies. Smith MR; Kantoff P Cancer Chemother Biol Response Modif; 1999; 18():394-417. PubMed ID: 10800495 [No Abstract] [Full Text] [Related]
28. Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8. Karakiewicz P; Perrotte P; Trinh QD; Patard JJ Eur Urol; 2007 Jun; 51(6):1478-80. PubMed ID: 17275988 [No Abstract] [Full Text] [Related]
29. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma. Harshman LC; Srinivas S Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749 [TBL] [Abstract][Full Text] [Related]
30. Extension of survival by resection of asynchronous renal cell carcinoma metastases to mediastinal lymph nodes. Whitson BA; Groth SS; Andrade RS; Garrett L; Dudek AZ; Jessurun J; Maddaus MA J Thorac Cardiovasc Surg; 2008 May; 135(5):1022-8. PubMed ID: 18455579 [TBL] [Abstract][Full Text] [Related]
31. Phase I/II study of thalidomide in combination with interleukin-2 in patients with metastatic renal cell carcinoma. Amato RJ; Morgan M; Rawat A Cancer; 2006 Apr; 106(7):1498-506. PubMed ID: 16475152 [TBL] [Abstract][Full Text] [Related]
32. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220 [TBL] [Abstract][Full Text] [Related]
37. Current treatment of renal cell carcinoma. De Mulder PH; van Herpen CM; Mulders PA Ann Oncol; 2004; 15 Suppl 4():iv319-28. PubMed ID: 15477330 [No Abstract] [Full Text] [Related]
38. Gastric metastasis from renal cancer six years after nephrectomy. Cruz A; Ramírez LM; Sánchez E; Ruiz M; Moreno I; López J; Sánchez F; De-Luna MM; Muntané J; Báez F; Padillo FJ Rev Esp Enferm Dig; 2011 Dec; 103(12):660-1. PubMed ID: 22217356 [No Abstract] [Full Text] [Related]